Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01485497

Evaluation of Obstructive Sleep Apnea With Long Range 3D Endoscopic Fourier Domain Optical Coherence Tomography (FDOCT)

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether the Optical coherence tomography (OCT) can image the structure and geometry of hollow organs of the upper airway in sleep disorder. The research can identify the obstruction sites that help the select the appropriate treatment for potential surgical candidates.

Detailed description

The National Commission on Sleep Disorders Research estimated that 18 million Americans suffer from obstructive sleep apnea (OSA) The majority of them are undiagnosed and untreated at this time. The current diagnostic gold standard for OSA is in-laboratory, a full night polysomnography (PSG). However, PSG is unable to provide information on upper airway structure and anatomy, and cannot identify the obstruction sites. OSA can lead to severe health complications including hypertension, heart failure, memory impairment, motor vehicle and work accidents, decreased work productivity, and increased risk of death.

Conditions

Interventions

TypeNameDescription
DEVICE3D endoscopic Fourier Domain OCTEvaluation of Obstructive Sleep Apnea

Timeline

Start date
2011-05-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2011-12-05
Last updated
2022-11-01

Source: ClinicalTrials.gov record NCT01485497. Inclusion in this directory is not an endorsement.